CRISPR Therapeutics AG (CRSP) Earnings
CRISPR Therapeutics AG is expected to report next earnings on August 3, 2026 (in NaN days), with a consensus EPS estimate of $-1.20. CRSP has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise +421.2% over the last four).
Next earnings
Aug 3, 2026in NaN days
EPS est $-1.20 · Revenue est $7M
Track record
Beat EPS in 5 of 12 quarters
Avg surprise +421.2% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 4, 2026 | $-1.20 | $-1.28 | -6.6% | $1M | -76.0% |
| Feb 12, 2026 | $-1.15 | $-1.37 | -19.1% | $864000 | -81.7% |
| Feb 21, 2024 | $-0.07 | $1.10 | +1671.4% | $200M | +611.5% |
| Feb 21, 2023 | $-2.32 | $-1.41 | +39.2% | $6000 | -73.9% |
| Nov 1, 2022 | $-2.30 | $-2.24 | +2.6% | $94000 | -94.9% |
| Feb 15, 2022 | $-1.74 | $-1.84 | -5.7% | $12M | +465.0% |
| Nov 3, 2021 | $-1.69 | $-1.67 | +1.2% | $329000 | -60.5% |
| Jul 29, 2021 | $3.52 | $9.44 | +168.2% | $900M | +6.4% |
| Feb 16, 2021 | $-1.23 | $-1.50 | -22.0% | $194000 | -92.2% |
| Oct 28, 2020 | $-1.17 | $-1.32 | -12.8% | $148000 | +11.9% |
| Jul 27, 2020 | $-0.92 | $-1.30 | -41.3% | $44000 | +36.8% |
| Apr 28, 2020 | $-1.09 | $-1.15 | -5.5% | $157000 | +9.5% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.